XT
TNGX icon

XTX Topco’s Tango Therapeutics TNGX Stock Holding History

XTX Topco’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
118,285
+104,190
+739% +$2.58M 0.05% 573
2026
Q1 		$295K Sell
14,095
-23,743
-63% -$330K 0.01% 2497
2025
Q4 		$335K Buy
+37,838
New +$326K 0.01% 1970
2025
Q3 		– Sell
-55,806
Closed -$286K – 3284
2025
Q2 		$286K Sell
55,806
-112,339
-67% -$278K 0.01% 1470
2025
Q1 		$230K Buy
168,145
+90,208
+116% +$222K 0.01% 1599
2024
Q4 		$241K Buy
77,937
+33,746
+76% +$157K 0.02% 1404
2024
Q3 		$340K Buy
44,191
+34,150
+340% +$326K 0.02% 1102
2024
Q2 		$86.2K Sell
10,041
-4,393
-30% -$33.9K 0.01% 1439
2024
Q1 		$115K Buy
+14,434
New +$155K 0.02% 1338
2023
Q2 		– Sell
-11,136
Closed -$44K – 1847
2023
Q1 		$44K Buy
+11,136
New +$64.6K 0.01% 1179
2022
Q3 		– Sell
-34,569
Closed -$157K – 1390
2022
Q2 		$157K Buy
+34,569
New +$209K 0.06% 529

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

XTX Topco's TNGX Position: Q2 2026 in Review

XTX Topco increased its Tango Therapeutics (TNGX) stake by 739% in Q2 2026, buying an estimated $2.58M and bringing the position to 118,285 shares worth $3.7M. The position accounts for 0.05% of the portfolio, ranked #573.

XTX Topco first reported a position in TNGX in Q2 2022 and has held it in 11 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • XTX Topco held 118,285 shares of Tango Therapeutics worth $3.7M as of Q2 2026.
  • XTX Topco bought 104,190 Tango Therapeutics shares in Q2 2026, an estimated $2.58M.
  • Tango Therapeutics made up 0.05% of XTX Topco's portfolio in Q2 2026, its #573 holding.
  • XTX Topco first reported a position in Tango Therapeutics in Q2 2022 and has held it in 11 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.